Naor Bar-Zeev, PHD, MBBS(HONS), MPH, MBIOSTAT

Associate Professor, International Health 
Global Disease Epidemiology and Control Program

The Department of International is pleased to welcome Naor Bar-Zeev, PhD, MBBS(Hons), MPH, MBiostat. Dr. Bar-Zeev joins the Department's Global Disease Epidemiology and Control (GDEC) Program and the International Vaccine Access Center (IVAC). Dr. Bar-Zeev’s work in IVAC will include serving as lead investigator on a seven-country randomized clinical trial of azithromycin in childhood diarrhea and as co-investigator on a randomized trial of a novel neonatal rotavirus vaccine, as well as establishing a typhoid cost-of-illness study in Malawi, in collaboration with PATH.

Dr. Bar-Zeev brings 20 years of experience in global child health across East Asia, the Pacific, and Africa. Prior to joining the Bloomberg School, Dr. Bar-Zeev was a Reader (Associate Professor) in Pediatric Infectious Diseases at the University of Liverpool, UK. While in Malawi, he worked as a vaccine epidemiologist at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme, where he led the Vaccines Research Group, and as a pediatric infectious diseases specialist at the Queen Elizabeth Central Hospital. In 2011, Dr. Bar-Zeev helped establish VacSurv, a multi-site national vaccine surveillance program in Malawi. Prior to his work in Malawi, Dr. Bar-Zeev worked in Darwin, Australia, and with the Western Pacific Regional Office of the WHO in Mongolia, Cambodia and the Pacific. He has also worked in Kenya, Tanzania, and Vietnam.

Contributor: Swati Sudarsan, Advocacy and Communications Specialist, IVAC